US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 1.7650
  • -0.0050-0.28%
Trading Mar 26 09:46 ET
361.83MMarket Cap-4.90P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.19M
Net income from continuing operations
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
Operating gains losses
-100.04%-16K
99.87%-83K
---75K
---195K
--337K
--36.95M
---63.51M
----
----
----
Depreciation and amortization
-9.19%1.25M
-16.94%304K
-11.18%294K
-6.12%322K
-1.81%325K
16.98%1.37M
1.10%366K
19.49%331K
25.64%343K
27.31%331K
Other non cash items
-85.22%1.37M
-120.97%-359K
-55.09%1.38M
-93.92%247K
-75.47%105K
167.01%9.27M
198.26%1.71M
399.35%3.07M
666.42%4.06M
-75.58%428K
Change In working capital
30.79%-12.47M
46.35%-2.6M
20.20%-5.88M
-437.94%-4.28M
105.96%298K
-197.27%-18.01M
-117.11%-4.85M
3.57%-7.37M
81.07%-796K
-345.43%-5M
-Change in prepaid assets
-96.56%207K
-59.11%819K
-121.18%-741K
-9.57%822K
-73.25%-693K
187.88%6.01M
1,754.63%2M
84.16%3.5M
575.92%909K
-247.60%-400K
-Change in payables and accrued expense
49.36%-4.34M
56.94%-1.4M
45.25%-3.35M
-678.55%-3.99M
3,938.53%4.4M
49.95%-8.57M
39.13%-3.25M
35.83%-6.12M
117.19%690K
-93.82%109K
-Change in other working capital
46.07%-8.33M
43.90%-2.02M
62.33%-1.79M
53.57%-1.11M
27.52%-3.41M
-146.04%-15.45M
---3.6M
---4.75M
---2.4M
---4.71M
Cash from discontinued investing activities
Operating cash flow
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.19M
Investing cash flow
Cash flow from continuing investing activities
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
-15.56%-3.49M
100.59%48K
65.87%-3.9M
Net PPE purchase and sale
90.33%-374K
111.76%2K
---35K
-518.75%-201K
96.41%-140K
81.24%-3.87M
99.26%-17K
--0
100.61%48K
53.72%-3.9M
Net intangibles purchase and sale
--0
--0
----
----
----
17.65%-3.5M
--0
----
----
----
Net other investing changes
-35.29%11K
----
----
----
----
127.87%17K
--7K
----
----
----
Cash from discontinued investing activities
Investing cash flow
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
-15.56%-3.49M
100.59%48K
65.87%-3.9M
Financing cash flow
Cash flow from continuing financing activities
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
136,637.86%140.63M
-96.60%377K
-245.79%-370K
Net issuance payments of debt
--0
----
----
----
----
---3.45M
----
----
----
----
Net common stock issuance
-45.46%76.78M
14.89%-360K
-95.27%6.66M
----
----
164.42%140.79M
-101.02%-423K
--140.71M
----
----
Proceeds from stock option exercised by employees
30.88%89K
--0
250.00%63K
--0
-48.00%26K
-73.12%68K
--0
126.47%18K
--0
-81.95%50K
Net other financing activities
81.77%-185K
100.80%3K
-30.93%-127K
89.43%-13K
88.57%-48K
27.50%-1.02M
-0.81%-375K
-177.14%-97K
79.80%-123K
-9.38%-420K
Cash from discontinued financing activities
Financing cash flow
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
136,637.86%140.63M
-96.60%377K
-245.79%-370K
Net cash flow
Beginning cash position
61.89%146.54M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
61.89%146.54M
-40.35%90.52M
351.82%166.92M
-30.72%47.72M
-33.45%66.06M
-40.35%90.52M
Current changes in cash
-108.75%-4.9M
8.46%-18.65M
-112.63%-15.06M
365.85%48.76M
18.38%-19.96M
191.51%56.02M
-138.03%-20.38M
473.27%119.2M
39.65%-18.34M
53.40%-24.46M
End cash Position
-3.35%141.64M
-3.35%141.64M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
61.89%146.54M
61.89%146.54M
351.82%166.92M
-30.72%47.72M
-33.45%66.06M
Free cash flow
-1.51%-81.6M
-13.46%-18.31M
-0.94%-21.65M
-15.95%-21.71M
17.22%-19.94M
29.02%-80.39M
-230.08%-16.13M
32.61%-21.45M
54.86%-18.72M
54.01%-24.09M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M37.70%-17.95M43.73%-18.77M50.69%-20.19M
Net income from continuing operations 19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M
Operating gains losses -100.04%-16K99.87%-83K---75K---195K--337K--36.95M---63.51M------------
Depreciation and amortization -9.19%1.25M-16.94%304K-11.18%294K-6.12%322K-1.81%325K16.98%1.37M1.10%366K19.49%331K25.64%343K27.31%331K
Other non cash items -85.22%1.37M-120.97%-359K-55.09%1.38M-93.92%247K-75.47%105K167.01%9.27M198.26%1.71M399.35%3.07M666.42%4.06M-75.58%428K
Change In working capital 30.79%-12.47M46.35%-2.6M20.20%-5.88M-437.94%-4.28M105.96%298K-197.27%-18.01M-117.11%-4.85M3.57%-7.37M81.07%-796K-345.43%-5M
-Change in prepaid assets -96.56%207K-59.11%819K-121.18%-741K-9.57%822K-73.25%-693K187.88%6.01M1,754.63%2M84.16%3.5M575.92%909K-247.60%-400K
-Change in payables and accrued expense 49.36%-4.34M56.94%-1.4M45.25%-3.35M-678.55%-3.99M3,938.53%4.4M49.95%-8.57M39.13%-3.25M35.83%-6.12M117.19%690K-93.82%109K
-Change in other working capital 46.07%-8.33M43.90%-2.02M62.33%-1.79M53.57%-1.11M27.52%-3.41M-146.04%-15.45M---3.6M---4.75M---2.4M---4.71M
Cash from discontinued investing activities
Operating cash flow -11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M37.70%-17.95M43.73%-18.77M50.69%-20.19M
Investing cash flow
Cash flow from continuing investing activities 95.06%-363K230.00%13K99.00%-35K-518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K-15.56%-3.49M100.59%48K65.87%-3.9M
Net PPE purchase and sale 90.33%-374K111.76%2K---35K-518.75%-201K96.41%-140K81.24%-3.87M99.26%-17K--0100.61%48K53.72%-3.9M
Net intangibles purchase and sale --0--0------------17.65%-3.5M--0------------
Net other investing changes -35.29%11K----------------127.87%17K--7K------------
Cash from discontinued investing activities
Investing cash flow 95.06%-363K230.00%13K99.00%-35K-518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K-15.56%-3.49M100.59%48K65.87%-3.9M
Financing cash flow
Cash flow from continuing financing activities -43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M136,637.86%140.63M-96.60%377K-245.79%-370K
Net issuance payments of debt --0-------------------3.45M----------------
Net common stock issuance -45.46%76.78M14.89%-360K-95.27%6.66M--------164.42%140.79M-101.02%-423K--140.71M--------
Proceeds from stock option exercised by employees 30.88%89K--0250.00%63K--0-48.00%26K-73.12%68K--0126.47%18K--0-81.95%50K
Net other financing activities 81.77%-185K100.80%3K-30.93%-127K89.43%-13K88.57%-48K27.50%-1.02M-0.81%-375K-177.14%-97K79.80%-123K-9.38%-420K
Cash from discontinued financing activities
Financing cash flow -43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M136,637.86%140.63M-96.60%377K-245.79%-370K
Net cash flow
Beginning cash position 61.89%146.54M-3.97%160.29M267.44%175.34M91.61%126.58M61.89%146.54M-40.35%90.52M351.82%166.92M-30.72%47.72M-33.45%66.06M-40.35%90.52M
Current changes in cash -108.75%-4.9M8.46%-18.65M-112.63%-15.06M365.85%48.76M18.38%-19.96M191.51%56.02M-138.03%-20.38M473.27%119.2M39.65%-18.34M53.40%-24.46M
End cash Position -3.35%141.64M-3.35%141.64M-3.97%160.29M267.44%175.34M91.61%126.58M61.89%146.54M61.89%146.54M351.82%166.92M-30.72%47.72M-33.45%66.06M
Free cash flow -1.51%-81.6M-13.46%-18.31M-0.94%-21.65M-15.95%-21.71M17.22%-19.94M29.02%-80.39M-230.08%-16.13M32.61%-21.45M54.86%-18.72M54.01%-24.09M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
+1.23%
Micron Technology
MU
+1.42%
Disney
DIS
+0.36%
Apple
AAPL
+0.30%
Alibaba
BABA
+0.22%

Unlock the Full List